Ligand Pharmaceuticals | LGND - Kapitał Pożyczkowy





Kapitał Pożyczkowy Zmiana Data
Agenus USD 169.66M 146.06M 2025-12
Amgen USD 50B 2.43B 2025-12
Arrowhead Research USD 538.1M 323.22M 2025-12
Baxter International USD 9.47B 726M 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Enanta Pharmaceuticals USD 0 0 2024-12
Enviri Corporation USD 1.53B 30.27M 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
GlaxoSmithKline GBP 14.71B 186M 2025-12
Glaxosmithkline GBP 19.82B 203.13M 2025-12
Heron Therapeutics USD 140.64M 975K 2025-12
Insmed USD 540.96M 1.24M 2025-12
Intrexon USD 0 198.67M 2024-06
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
Ligand Pharmaceuticals USD 445.49M 445.44M 2025-09
MacroGenics USD 70M 256K 2025-12
Merck USD 39.97B 6B 2025-09
Pacira USD 372.19M 4.53M 2025-12
Pfizer USD 57.41B 93M 2025-09
Rigel Pharmaceuticals USD 0 0 2024-09
Sangamo BioSciences USD 0 0 2022-06
Veracyte USD 0 0 2025-03